200,000+ products from a single source!

sales@angenechem.com

Home > Oxazole > 127-48-0

127-48-0

127-48-0 | 2,4-Oxazolidinedione, 3,5,5-trimethyl-

CAS No: 127-48-0 Catalog No: AG000WIU MDL No:MFCD00047084

Product Description

Catalog Number:
AG000WIU
Chemical Name:
2,4-Oxazolidinedione, 3,5,5-trimethyl-
CAS Number:
127-48-0
Molecular Formula:
C6H9NO3
Molecular Weight:
143.1406
MDL Number:
MFCD00047084
IUPAC Name:
3,5,5-trimethyl-1,3-oxazolidine-2,4-dione
InChI:
InChI=1S/C6H9NO3/c1-6(2)4(8)7(3)5(9)10-6/h1-3H3
InChI Key:
IRYJRGCIQBGHIV-UHFFFAOYSA-N
SMILES:
O=C1OC(C(=O)N1C)(C)C
EC Number:
204-845-8
UNII:
R7GV3H6FQ4

Properties

Complexity:
197  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
143.058g/mol
Formal Charge:
0
Heavy Atom Count:
10  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
143.142g/mol
Monoisotopic Mass:
143.058g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
46.6A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
0.3  

Literature

Title Journal
Discriminating between adaptive and carcinogenic liver hypertrophy in rat studies using logistic ridge regression analysis of toxicogenomic data: The mode of action and predictive models. Toxicology and applied pharmacology 20170301
[Toxic effects of trimethadione on zebrafish early development]. Yi chuan = Hereditas 20120901
Update on endoscopic management of main pancreatic duct stones in chronic calcific pancreatitis. The Korean journal of internal medicine 20120301
Induction of specific immunotherapy with hymenoptera venoms using ultrarush regimen in children: safety and tolerance. Journal of allergy 20120101
Genetic polymorphisms in CYP2E1: association with schizophrenia susceptibility and risperidone response in the Chinese Han population. PloS one 20120101
Short-term long chain omega3 diet protects from neuroinflammatory processes and memory impairment in aged mice. PloS one 20120101
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). PLoS computational biology 20111201
Treatment of myasthenia gravis based on its immunopathogenesis. Journal of clinical neurology (Seoul, Korea) 20111201
Co-variation in frequency and severity of cardiovascular and skeletal defects in Sprague-Dawley rats after maternal administration of dimethadione, the N-demethylated metabolite of trimethadione. Birth defects research. Part B, Developmental and reproductive toxicology 20110601
Zebrafish (Danio rerio) embryos as a model for testing proteratogens. Toxicology 20110315
Cognitive and emotional alterations are related to hippocampal inflammation in a mouse model of metabolic syndrome. PloS one 20110101
Studies of properties of 'Pain Networks' as predictors of targets of stimulation for treatment of pain. Frontiers in integrative neuroscience 20110101
Intrauterine growth retardation and nonalcoholic Fatty liver disease in children. International journal of endocrinology 20110101
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals 20101201
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. Bioorganic & medicinal chemistry letters 20101101
Lamotrigine extends lifespan but compromises health span in Drosophila melanogaster. Biogerontology 20100201
Allyl isothiocyanate that induces GST and UGT expression confers oxidative stress resistance on C. elegans, as demonstrated by nematode biosensor. PloS one 20100101
Neuroprotective effects of blockers for T-type calcium channels. Molecular neurodegeneration 20090101
Treatment of Lennox-Gastaut syndrome: overview and recent findings. Neuropsychiatric disease and treatment 20081201
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry 20081113
The anticonvulsant ethosuximide disrupts sensory function to extend C. elegans lifespan. PLoS genetics 20081001
Valproic acid extends Caenorhabditis elegans lifespan. Aging cell 20080601
Design and synthesis of 6-amino-1,4-oxazepane-3,5-dione derivatives as novel broad spectrum anticonvulsants. Bioorganic & medicinal chemistry letters 20080601
Etiology of congenital dislocation of the hip : Carl E. Badgley MD (1893-1973). The 11th president of the AAOS 1942. Clinical orthopaedics and related research 20080101
Effect of optical flow versus attentional strategy on gait in Parkinson's Disease: a study with a portable optical stimulating device. Journal of neuroengineering and rehabilitation 20080101
Prophylactic and therapeutic functions of T-type calcium blockers against noise-induced hearing loss. Hearing research 20070401
Classification and diagnosis of ear malformations. GMS current topics in otorhinolaryngology, head and neck surgery 20070101
The ethics of excluding women who become pregnant while participating in clinical trials of anti-epileptic medications. Seizure 20061201
Pharmacology of delayed aging and extended lifespan of Caenorhabditis elegans. Experimental gerontology 20061001
Education and imaging. Hepatobiliary and pancreatic: oral therapy for pancreatic duct stones. Journal of gastroenterology and hepatology 20060901
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Effects of anticonvulsant drugs on life span. Archives of neurology 20060401
The history of barbiturates a century after their clinical introduction. Neuropsychiatric disease and treatment 20051201
The antihyperalgesic effects of the T-type calcium channel blockers ethosuximide, trimethadione, and mibefradil. European journal of pharmacology 20051003
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure. Journal of pharmaceutical sciences 20050701
Oral litholysis therapy for endoscopically unretrievable obstructive pancreatic stones. Pancreas 20050501
Adulteration of South African traditional herbal remedies. Therapeutic drug monitoring 20050201
Anticonvulsant medications extend worm life-span. Science (New York, N.Y.) 20050114
Postnatal closure of membranous ventricular septal defects in Sprague-Dawley rat pups after maternal exposure with trimethadione. Birth defects research. Part B, Developmental and reproductive toxicology 20040601
Involvement of cytochrome P450 2C9, 2E1 and 3A4 in trimethadione N-demethylation in human microsomes. Journal of clinical pharmacy and therapeutics 20031201
Embryonic arrhythmia by inhibition of HERG channels: a common hypoxia-related teratogenic mechanism for antiepileptic drugs? Epilepsia 20020501
Determination of trimetazidine HCl by adsorptive stripping square-wave voltammetry at a glassy carbon electrode. Journal of pharmaceutical and biomedical analysis 20020101
The clinical importance of the trimethadione tolerance test as a method for quantitative assessment of hepatic functional reserve in patients with biliary atresia. Journal of clinical pharmacy and therapeutics 20011201
Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy. Epilepsy research 20011201
[Fetal trimethadione syndrome]. Ryoikibetsu shokogun shirizu 20010101
Anticonvulsants for soman-induced seizure activity. Journal of biomedical science 19990101
Trimethadione N-demethylation by rat liver CYP2E1 in vitro. Research communications in molecular pathology and pharmacology 19960701
Characterization of the antiabsence effects of SCH 50911, a GABA-B receptor antagonist, in the lethargic mouse, gamma-hydroxybutyrate, and pentylenetetrazole models. The Journal of pharmacology and experimental therapeutics 19950901
Dissolution of pancreatic stones by oral trimethadione in patients with chronic calcific pancreatitis. Journal of gastroenterology and hepatology 19940101
Effects of the oxazolidinedione anticonvulsants trimethadione and dimethadione and the barbiturate homolog 5,5-dimethylbarbituric acid on N-nitrosodiethylamine-initiated renal and hepatic carcinogenesis in the F344/NCr rat. Archives of toxicology 19920101
Anticonvulsive and convulsive effects of lidocaine: comparison with those of phenytoin, and implications for mechanism of action concepts. Neurological research 19880901
Effects of antiepileptic drugs on absence-like and tonic seizures in the spontaneously epileptic rat, a double mutant rat. Epilepsia 19880101
Only certain antiepileptic drugs prevent seizures induced by pilocarpine. Brain research 19870701
Use of ethosuximide and valproate in the treatment of epilepsy. Neurologic clinics 19860801
Antiepileptic drug evaluation in a new animal model: spontaneous petit mal epilepsy in the rat. Arzneimittel-Forschung 19850101
Fetal anticonvulsant syndrome in rats: effects on postnatal behavior and brain amino acid content. Neurobehavioral toxicology and teratology 19850101
A model of chronic spontaneous petit mal-like seizures in the rat: comparison with pentylenetetrazol-induced seizures. Epilepsia 19840601
Fetal anticonvulsant syndrome in rats: dose- and period-response relationships of prenatal diphenylhydantoin, trimethadione and phenobarbital exposure on the structural and functional development of the offspring. The Journal of pharmacology and experimental therapeutics 19831101
Comparison of the actions of trimethadione and chlordiazepoxide in animal models of anxiety and benzodiazepine receptor binding. Neuropharmacology 19821101
Anticonvulsants specific for petit mal antagonize epileptogenic effect of leucine enkephalin. Science (New York, N.Y.) 19801128
Troxidone (trimethadione) embryopathy: case report with reveiw of the literature. Clinical and experimental neurology 19790101
Phenotypic malformations in association with maternal trimethadione therapy. The Journal of pediatrics 19780201
Anti-convulsant effect of phthalazino-2,3b-phthalazine-5(14H),12(7h)-dione (L-5418). I. Behavioral effect. Japanese journal of pharmacology 19780201
The fetal trimethadione syndrome: report of an additional family and further delineation of this syndrome. American journal of diseases of children (1960) 19771201
[Quantitative analysis of conditional-optimal doses of succilep and trimetin in the treatment of children and adolescents with minor forms of epilepsy]. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952) 19770101
Measurement of anticonvulsant activity in the Papio papio model of epilepsy. Federation proceedings 19760901
Cardiac defects in children of mothers receiving anticonvulsant therapy during pregnancy. The Journal of pediatrics 19760801
Di-n-propylacetic acid--profile of anticonvulsant activity in mice. Arzneimittel-Forschung 19760201
The fetal trimethadione syndrome. The Journal of pediatrics 19750801
Fetal anomalies following maternal trimethadione ingestion. The Journal of pediatrics 19730501
Trimethadione (Tridione)-induced nephrotic syndrome. A report of a case with unique ultrastructural renal pathology. The American journal of medicine 19730201
Possible teratogenicity of trimethadione and paramethadione. Lancet (London, England) 19700801
Pharmacologic interactions of albutoin with other anticonvulsant drugs. The Journal of pharmacology and experimental therapeutics 19700801
Myasthenia gravis syndrome associated with trimethadione. JAMA 19700629
Successful therapy of trimethadione nephrosis with prednisone and cyclophosphamide. Report of a case. The Journal of pediatrics 19670801
Nephrotic syndrome caused by probenecid. JAMA 19670102

© 2019 Angene International Limited. All rights Reserved.